-+ 0.00%
-+ 0.00%
-+ 0.00%

ALTIMMUNE ANNOUNCES DATA FROM RECLAIM PHASE 2 TRIAL OF PEMVIDUTIDE IN ALCOHOL USE DISORDER SELECTED AS LATE-BREAKING ORAL PRESENTATION AT AASLD THE LIVER MEETING® 2026

Reuters·11/05/2026 15:00:00

Please log in to view news